From: Molecular analyses of triple-negative breast cancer in the young and elderly
Subset of patients | N | OS | IDFS | DRFI |
---|---|---|---|---|
All patients | 149 | HR = 1.04, 95% CI = 0.996–1.078, p = 0.08 | HR = 1.02, 95% CI = 0.991–1.05, p = 0.18 | HR = 1, 95% CI = 0.967–1.036, p = 0.98 |
HRDetect-high | 99 | HR = 1.046, 95% CI = 0.989–1.106, p = 0.12 | HR = 1.008, 95% CI = 0.968–1.049, p = 0.71 | HR = 0.977, 95% CI = 0.928–1.028, p = 0.365 |
HRDetect-low/intermediate | 50 | HR = 1.0, 95% CI = 0.938–1.067, p = 0.99 | HR = 1.003, 95% CI = 0.954–1.055, p = 0.90 | HR = 0.983, 95% CI = 0.928–1.042, p = 0.565 |